Operations | Monitoring | ITSM | DevOps | Cloud

For any company operating in an FDA-regulated industry, the inspection is the moment of truth. It is when the quality and compliance systems a company has built, or failed to build, are examined by investigators trained to find exactly the gaps a company hopes it does not have. A successful inspection reflects systems that were designed to withstand scrutiny; a difficult one, with findings and follow-up, reflects systems that were not. The difference is rarely luck. It comes down to whether a company has built genuine, robust quality and compliance systems well before an inspector ever arrives.

It's getting harder and harder to distinguish between content produced by people and content produced by machines on the internet. AI can now create convincing articles, images, audio and video that may not be immediately recognized as being AI-generated. Europe has decided that this uncertainty cannot be left to users to deal with on their own. The EU AI Act introduces new transparency obligations, which are beginning to establish a more structured framework for identifying synthetic content.

A family pulls their daughter out of school in March, planning to finish sixth grade at home and re-enroll her in the fall. In September the district registrar asks for an account of the spring: days of instruction, subjects covered, evidence of progress. What the parents have is a stack of finished workbooks, a library card with a long history, and a phone full of undated photos. They spend a weekend reconstructing five months from memory.

If you have been staying updated on trends, you already know that the EU data act is actually very quickly turning into one of the most important regulations for companies that manage business data and customers in Europe. Understandably, many companies have already been adjusting to privacy laws over the past few years. However, this new regulation has brought on different challenges.